Average Co-Inventor Count = 4.75
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (286 from 289 patents)
2. Abbott Laboratories Corporation (43 from 4,177 patents)
3. Abbvie Inc. (4 from 822 patents)
4. Other (2 from 832,575 patents)
5. Pic Therapeutics, Inc. (2 from 5 patents)
6. Novartis Ag (1 from 3,923 patents)
7. Elmore Patent Law Group, P.c. (1 from 1 patent)
8. Enata Pharmacueticals, Inc. (1 from 1 patent)
9. Emata Pharmaceuticals, Inc (1 from 1 patent)
10. Enanta Pharmacueticals, Inc. (1 from 1 patent)
11. Abbvie Bahamas Limited (6 patents)
12. Abbvie Ireland Unlimited Company (0 patent)
339 patents:
1. 12459923 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
2. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents
3. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
4. 12358921 - Antiviral heterocyclic compounds
5. 12297209 - Benzodiazepine derivatives as RSV inhibitors
6. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
7. 12268694 - Combination pharmaceutical agents as RSV inhibitors
8. 12264159 - Functionalized heterocycles as antiviral agents
9. 12162857 - Antiviral compounds
10. 12157731 - EIF4E inhibitors and uses thereof
11. 12145941 - Heterocyclic antiviral agents
12. 12145942 - Spiropyrrolidine derived antiviral agents
13. 12054493 - Hepatitis B antiviral agents
14. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
15. 12011425 - Hepatitis B antiviral agents